The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: A haplotype relative risk study and association with clozapine response

Molecular Psychiatry

Volumn 3, Issue 1, 1998, Pages 72-75

  Malhotra, A K ^a   Goldman, D ^b   Buchanan, R W ^c   Rooney, W ^a   Clifton, A ^a   Kosmidis, M H ^a   Breier, A ^a   Pickar, D ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Association; Clozapine; Dopamine 3 receptor; Genetics; Polymorphism; Schizophrenia

Indexed keywords

CLOZAPINE; DOPAMINE 3 RECEPTOR; DOPAMINE 2 RECEPTOR; DRD3 PROTEIN, HUMAN; GLYCINE; NEUROLEPTIC AGENT; SERINE;

ADULT; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA; CHILD; GENETICS; HAPLOTYPE; HETEROZYGOTE DETECTION; NUCLEAR FAMILY; POINT MUTATION; POLYMERASE CHAIN REACTION; RISK;

ALLELES; ANTIPSYCHOTIC AGENTS; CHILD; CLOZAPINE; FEMALE; GENOTYPE; GLYCINE; HAPLOTYPES; HETEROZYGOTE DETECTION; HUMANS; MALE; NUCLEAR FAMILY; POINT MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RISK; SCHIZOPHRENIA; SERINE;

EID: 0031594223     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000288     Document Type: Article

References (18)

1. 2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci 1994; 91: 11271-11275.
2. 3) as a novel target for antipsychotics. Biochem Pharmacol 1992; 43: 659-666.
3. 3 receptor mRNA levels. Neuropharmacology 1093; 32: 901-907.
4. 3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 1992; 2: 249-256.
5. 3 receptor gene and schizophrenia. Hum Genet 1996; 97: 714-719.
6. 3 receptor gene. J Med Genet 1992; 29: 858-860.
7. 3 receptor gene and schizophrenia. Am J Med Genet 1994; 54: 21-26.
8. Terwilliger J, Ott J. A haplotype-based 'Haplotype Relative Risk' approach to detecting allelic associations. Hum Hered 1992; 42: 337-346.
9. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates: Hillsdale, NJ, 1988.
10. 3 receptor gene in schizophrenia not confirmed. J Med Genet 1993; 30: 708.
11. 3 receptor gene. Acta Psychiatr Scand 1993; 87: 345-349.
12. 3 receptor in an Italian psychotic population. Psychiatr Genet 1994; 4: 39-42.
13. 3 receptor locus is not associated with schizophrenia. J Med Genet 1994; 31: 260.
14. 3 receptor gene. Hum Genet 1993; 92: 336-338.
15. 3 dopamine receptor gene. Am J Med Genet 1993; 48: 83-86.
16. 3 receptor gene polymorphism (Bal/1) in Chinese schizophrenic males. Psychiatr Genet 1994; 4: 201-204.
17. Kane J, Honigfeld G, Singer J, Meltzer H, the Clozaril Collaborative Study Group. Clozapine for the treatment resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psych 1988; 45: 789-796.
18. Pickar D, Owen RR, Litman RE, Konicki E, Gutierrez R, Rapaport MH. Clinical and biological response to clozapine in patients with schizophrenia: crossover comparison with fluphenazine. Arch Gen Psych 1992; 49: 345-353.